Bank of New York Mellon Corp - USANA HEALTH SCIENCES INC ownership

USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 176 filers reported holding USANA HEALTH SCIENCES INC in Q2 2019. The put-call ratio across all filers is 7.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of USANA HEALTH SCIENCES INC
ValueSharesWeighting
Q3 2023$6,782,878
-12.4%
115,729
-5.8%
0.00%
-50.0%
Q2 2023$7,743,896
+2.8%
122,841
+2.5%
0.00%0.0%
Q1 2023$7,535,044
+11.4%
119,794
-5.8%
0.00%0.0%
Q4 2022$6,763,581
+0.8%
127,135
+6.2%
0.00%0.0%
Q3 2022$6,710,000
-17.9%
119,708
+5.9%
0.00%0.0%
Q2 2022$8,177,000
-13.9%
113,015
-5.4%
0.00%0.0%
Q1 2022$9,492,000
-21.6%
119,476
-0.1%
0.00%0.0%
Q4 2021$12,100,000
-1.0%
119,557
-9.8%
0.00%0.0%
Q3 2021$12,220,000
-8.8%
132,542
+1.4%
0.00%
-33.3%
Q2 2021$13,395,000
+1.0%
130,773
-3.8%
0.00%0.0%
Q1 2021$13,265,000
+29.7%
135,913
+2.4%
0.00%
+50.0%
Q4 2020$10,230,000
+3.3%
132,697
-1.3%
0.00%0.0%
Q3 2020$9,906,000
-6.8%
134,507
-7.1%
0.00%
-33.3%
Q2 2020$10,632,000
+21.2%
144,788
-4.7%
0.00%0.0%
Q1 2020$8,774,000
-28.6%
151,907
-2.9%
0.00%0.0%
Q4 2019$12,286,000
+23.7%
156,405
+7.7%
0.00%0.0%
Q3 2019$9,934,000
-24.2%
145,263
-12.0%
0.00%
-25.0%
Q2 2019$13,113,000
+1.1%
165,076
+6.8%
0.00%0.0%
Q1 2019$12,969,000
+21.6%
154,628
+70.7%
0.00%
+33.3%
Q4 2018$10,668,000
-20.9%
90,609
-19.0%
0.00%0.0%
Q3 2018$13,485,000
+4.3%
111,857
-0.2%
0.00%
-25.0%
Q2 2018$12,926,000
+64.3%
112,111
+22.4%
0.00%
+100.0%
Q1 2018$7,869,000
+26.3%
91,601
+8.9%
0.00%0.0%
Q4 2017$6,229,000
+17.2%
84,132
-8.7%
0.00%
+100.0%
Q3 2017$5,317,000
-8.0%
92,137
+2.2%
0.00%
-50.0%
Q2 2017$5,782,000
+26.2%
90,193
+13.4%
0.00%
+100.0%
Q1 2017$4,580,000
-60.3%
79,523
-57.9%
0.00%
-66.7%
Q4 2016$11,546,000
-5.8%
188,670
+113.0%
0.00%
-25.0%
Q3 2016$12,252,000
+21.7%
88,563
-2.0%
0.00%
+33.3%
Q2 2016$10,071,000
-12.0%
90,386
-4.1%
0.00%0.0%
Q1 2016$11,447,000
+0.8%
94,273
+6.1%
0.00%0.0%
Q4 2015$11,353,000
-8.2%
88,866
-3.7%
0.00%
-25.0%
Q3 2015$12,372,000
-7.6%
92,303
-5.8%
0.00%0.0%
Q2 2015$13,393,000
+22.2%
98,005
-0.7%
0.00%
+33.3%
Q1 2015$10,964,000
+135.8%
98,672
+117.7%
0.00%
+200.0%
Q4 2014$4,649,000
+17.9%
45,318
-15.3%
0.00%0.0%
Q3 2014$3,943,000
-65.2%
53,526
-63.0%
0.00%
-50.0%
Q2 2014$11,316,000
-20.3%
144,818
-23.1%
0.00%
-50.0%
Q1 2014$14,192,000
-1.0%
188,369
-0.7%
0.00%0.0%
Q4 2013$14,334,000
-56.5%
189,657
-50.1%
0.00%
-20.0%
Q3 2013$32,968,000
+119.0%
379,868
+82.6%
0.01%0.0%
Q2 2013$15,056,000208,0100.01%
Other shareholders
USANA HEALTH SCIENCES INC shareholders Q2 2019
NameSharesValueWeighting ↓
HAYS ADVISORY LLC 71,761$4,133,0000.97%
Matarin Capital Management, LLC 137,429$7,915,911,0000.78%
Phocas Financial Corp. 119,515$6,884,0000.64%
RAMSEY QUANTITATIVE SYSTEMS 8,808$507,0000.58%
Polianta Ltd 11,620$669,0000.40%
LOMBARDIA CAPITAL PARTNERS LLC 7,309$421,0000.38%
Quotient Investors, LLC 10,500$605,0000.36%
CLARK ESTATES INC/NY 40,000$2,304,0000.36%
ALGERT GLOBAL LLC 21,843$1,258,0000.34%
GLOBEFLEX CAPITAL L P 21,243$1,224,0000.29%
View complete list of USANA HEALTH SCIENCES INC shareholders